Sign up to save your podcasts
Or
Share Episode 458: #UromigosLive 2025 - Mock ODAC on Sasanlimab and Durvalumab in BCG-naive NMIBC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 458: #UromigosLive 2025 - Mock ODAC on Sasanlimab and Durvalumab in BCG-naive NMIBC
Brian takes the role of FDA and critically appraises the data. Then Tom (CREST) and Jonathan Rosenberg (POTOMAC) defend the data on behalf of each Sponsor. Our expert panel then asks tough questions and votes for or against approval.
View all episodes
By The Uromigos
4.9
5555 ratings
Brian takes the role of FDA and critically appraises the data. Then Tom (CREST) and Jonathan Rosenberg (POTOMAC) defend the data on behalf of each Sponsor. Our expert panel then asks tough questions and votes for or against approval.
More shows like The Uromigos
View all
JAMA Editors' Summary
140 Listeners
NEJM This Week
318 Listeners
AFP: American Family Physician Podcast
700 Listeners
JAMA Clinical Reviews
499 Listeners
Prostate Cancer Update
14 Listeners
ASCO Daily News
58 Listeners
White Coat Investor Podcast
2,445 Listeners
The Curbsiders Internal Medicine Podcast
3,349 Listeners
The Peter Attia Drive
9,202 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
512 Listeners
GU Cast | Urology Podcast
2 Listeners
BioCentury This Week
34 Listeners
Two Onc Docs
190 Listeners
The View on GU | with Lalani and Wallis
2 Listeners